Clinical Trials Browser

Withdrawn × Interventional × Lopinavir × Clear all

NCT01165645 2022-12-01

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

Phase NA Withdrawn

Hodgkin Disease

NCT04455958 2021-04-26

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Phase 2 Withdrawn

Other hematologic neoplasm

Hematologic Neoplasms